Silke Miller
Johnson & Johnson (United States)(US)
Publications by Year
Research Areas
Cardiac Imaging and Diagnostics, Advanced MRI Techniques and Applications, Receptor Mechanisms and Signaling, Phosphodiesterase function and regulation, Ultrasound and Hyperthermia Applications
Most-Cited Works
- → Vortioxetine (Lu AA21004), a novel multimodal antidepressant, enhances memory in rats(2013)294 cited
- → Pharmacological Effects of Lu AA21004: A Novel Multimodal Compound for the Treatment of Major Depressive Disorder(2011)266 cited
- → Long-acting MIC-1/GDF15 molecules to treat obesity: Evidence from mice to monkeys(2017)227 cited
- → Therapeutic approaches to enhance PINK1/Parkin mediated mitophagy for the treatment of Parkinson’s disease(2019)126 cited
- → PAC1 receptor blockade reduces central nociceptive activity: new approach for primary headache?(2020)114 cited
- → Antidepressant and anxiolytic potential of the multimodal antidepressant vortioxetine (Lu AA21004) assessed by behavioural and neurogenesis outcomes in mice(2013)112 cited
- → Immunohistochemical localization of the calcitonin gene-related peptide binding site in the primate trigeminovascular system using functional antagonist antibodies(2016)71 cited
- → The Novel Neuropeptide Y Y5 Receptor Antagonist Lu AA33810 [N-[[trans-4-[(4,5-Dihydro[1]benzothiepino[5,4-d]thiazol-2-yl)amino]cyclohexyl]methyl]-methanesulfonamide] Exerts Anxiolytic- and Antidepressant-Like Effects in Rat Models of Stress Sensitivity(2008)60 cited
- → The effects of stressful stimuli and hypothalamic–pituitary–adrenal axis activation are reversed by the melanin-concentrating hormone 1 receptor antagonist SNAP 94847 in rodents(2008)43 cited
- → The effects of acute treatment with escitalopram on the different stages of contextual fear conditioning are reversed by atomoxetine(2010)37 cited